Cargando…

Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

BACKGROUND: Fatigue has a major influence on the quality of life of people with multiple sclerosis. The Fatigue Severity Scale is a frequently used patient-reported measure of fatigue impact, but does not generate the health state utility values required to inform cost-effectiveness analysis, limiti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Goodwin, E., Hawton, A., Green, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683407/ https://www.ncbi.nlm.nih.gov/pubmed/31382960 http://dx.doi.org/10.1186/s12955-019-1205-y

Ejemplares similares

The External Validity of Mapping MSIS-29 on EQ-5D Among Individuals With Multiple Sclerosis in Sweden
por: Ernstsson, Olivia, et al.
Publicado: (2017)

Mapping the PHQ-8 to EQ-5D, HUI3 and SF6D in patients with depression
por: Abdin, Edimansyah, et al.
Publicado: (2021)

The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials
por: Strijbis, Eva MM, et al.
Publicado: (2022)

Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?
por: Rowen, Donna, et al.
Publicado: (2009)

Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D
por: Teckle, Paulos, et al.
Publicado: (2013)

Level of agreement between patient-reported EQ-5D responses and EQ-5D responses mapped from the SF-12 in an injury population
por: Gabbe, Belinda J, et al.
Publicado: (2015)

Comparison of the SF-6D and the EQ-5D in patients with coronary heart disease
por: van Stel, Henk F, et al.
Publicado: (2006)

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
por: Yousefi, Mahmood, et al.
Publicado: (2016)

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D
por: Shiroiwa, Takeru, et al.
Publicado: (2015)

The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
por: Harrison, M. J., et al.
Publicado: (2009)

Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke
por: Kim, Sang-Kyu, et al.
Publicado: (2015)

Rasch analysis of the Multiple Sclerosis Impact Scale (MSIS-29)
por: Ramp, Melina, et al.
Publicado: (2009)

An empirical evaluation of the SF-12, SF-6D, EQ-5D and Michigan Hand Outcome Questionnaire in patients with rheumatoid arthritis of the hand
por: Dritsaki, Melina, et al.
Publicado: (2017)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain
por: Barton, Garry R, et al.
Publicado: (2009)

Comparison between EQ-5D and SF-6D Utility in Rural Residents of Jiangsu Province, China
por: Jin, Hui, et al.
Publicado: (2012)

Mapping of the Gastrointestinal Short Form Questionnaire (GSF-Q) into EQ-5D-3L and SF-6D in patients with gastroesophageal reflux disease
por: Monroy, Manuel, et al.
Publicado: (2018)

A Comparison between the EQ-5D and the SF-6D in Patients with Chronic Obstructive Pulmonary Disease (COPD)
por: Chen, Jing, et al.
Publicado: (2014)

Estimating the disutility of relapse in relapsing–remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models
por: Ahmad, Hasnat, et al.
Publicado: (2023)

Deriving a mapping algorithm for converting SF-36 scores to EQ-5D utility score in a Korean population
por: Kim, Seon-Ha, et al.
Publicado: (2014)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Comparing the MSIS-29 and the Health Utilities Index Mark III in Multiple Sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2021)

The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes
por: Mulhern, Brendan, et al.
Publicado: (2014)

Comparison of the psychometric properties of the EQ-5D-3L and SF-6D in the general population of Chengdu city in China
por: Zhao, Longchao, et al.
Publicado: (2019)

A head-to-head comparison of EQ-5D-5 L and SF-6D in Chinese patients with low back pain
por: Ye, Ziping, et al.
Publicado: (2019)

A Comparison of EQ-5D-3L, EQ-5D-5L, and SF-6D Utilities of Patients with Musculoskeletal Disorders of Different Severity: A Health-Related Quality of Life Approach
por: Kontodimopoulos, Nikolaos, et al.
Publicado: (2022)

Mapping onto Eq-5 D for patients in poor health
por: Versteegh, Matthijs M, et al.
Publicado: (2010)

Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis
por: Harrison, Mark J, et al.
Publicado: (2010)

Comparison of the SF6D, the EQ5D, and the oswestry disability index in patients with chronic low back pain and degenerative disc disease
por: Johnsen, Lars G, et al.
Publicado: (2013)

Estimating the burden of disease in chronic pain with and without neuropathic characteristics: Does the choice between the EQ-5D and SF-6D matter?
por: Torrance, Nicola, et al.
Publicado: (2014)

Assessment of health-related quality of life in individuals with depressive symptoms: validity and responsiveness of the EQ-5D-3L and the SF-6D
por: Stolz, Maike, et al.
Publicado: (2022)

Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey
por: Kularatna, Sanjeewa, et al.
Publicado: (2019)

Adjustment of foreign EQ-5D-3L utilities can increase their transferability
por: Oddershede, Lars, et al.
Publicado: (2015)

Performance of the EQ-5D and the EQ-5D+C in elderly patients with cognitive impairments
por: Wolfs, Claire AG, et al.
Publicado: (2007)

Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
por: Wille, Nora, et al.
Publicado: (2010)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

MSIS: Multispectral Instance Segmentation Method for Power Equipment
por: Shu, Jun, et al.
Publicado: (2022)

Measuring Health Spillover Effects in Caregivers of Children with Autism Spectrum Disorder: A Comparison of the EQ-5D-3L and SF-6D
por: Brown, Clare C., et al.
Publicado: (2019)

Mapping From Visual Acuity to EQ-5D, EQ-5D With Vision Bolt-On, and VFQ-UI in Patients With Macular Edema in the LEAVO Trial
por: Pennington, Becky M., et al.
Publicado: (2020)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e6v309148hkn3n4opcav2i8h68